Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Unique study compares how bat and human cells respond to viruses
bat
"By doing this we are at the beginning of understanding why these viruses are so dangerous to us and so benign to bats."
Fruit bats carry viruses which can be dangerous to humans but are benign to bats

Scientists from the University of Bristol, together with CSIRO's Australian Animal Health Laboratories (AHHL) have been using cutting edge techniques to comprehensively compare the response of bat and human cells to a highly dangerous bat virus.

This is the first time that scientists have been able to study how cells from these two species respond to the same virus on a side-by-side basis.

The research focusses on the bat-borne Hendra virus which, like the Ebola virus, is not dangerous to bats but very dangerous to humans and some other animals.

In the study, the team at AAHL infected human cells with the Hendra virus and studied how the virus affects genes and proteins in the infected cells. At the same time, they also infected bat cells with the same virus and studied how the they responded.

Using a supercomputer, the research team identified about six thousand genes and proteins made by the bats and examined how they changed in response to the Hendra virus. A similar analysis was also carried out on the human cells.

The scientists found that human and bat cells respond very differently to the same virus. The bat cells responded robustly and quickly to the infection, triggering biochemical pathways that are known to be potentially helpful in other virus infections.

Conversely, the human cells were slower to respond to the virus. This indicates that human cells take longer to realise there is an infection and trigger the biochemical pathways that might protect someone from the infection becoming fatal.

Dr Michelle Baker, who headed the team at AAHL, said: "As with all fundamental scientific work there is a long way to go but we have shown how to compare two different animals (bats and humans) side by side and look at how thousands of genes and proteins respond to the same bat virus.

By doing this we are at the beginning of understanding why these viruses are so dangerous to us and so benign to bats. Indeed the kind of bat cells we use in this experiment are from a similar type of fruit bat as those which harbour Ebola virus in Africa."

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.